Abstract:Background: The mechanisms underlying the occurrence and development of esophageal squamous cell carcinoma (ESCC) remains to be elucidated. The present study aims to investigate the roles and implications of IGF2BP1 overexpression in ESCC. Methods: IGF2BP1 protein expression in ESCC samples was assessed by immunohistochemistry (IHC), and the mRNA abundance of IGF2BP1 and INHBA was analyzed with TCGA datasets and by RNA in situ hybridization (RISH). The methylation level of the IGF2BP1 promoter region was detected by methylation-specific PCR (MSP-PCR). Cell viability, migration, invasion and in vivo metastasis assays were performed to explore the roles of IGF2BP1 overexpression in ESCC. RNA immunoprecipitation sequencing (RIP-seq) and mass spectrometry were applied to identify the target RNAs and interacting proteins of IGF2BP1, respectively. RIP-PCR, RNA pulldown, immunofluorescence (IF), gene-specific m6A PCR and RNA stability assays were used to uncover the molecular mechanisms underlying the malignant phenotypes of ESCC cells caused by IGF2BP1 dysregulation. BTYNB, a small molecular inhibitor of IGF2BP1, was evaluated for its inhibitory effect on the malignant phenotypes of ESCC cells. Results: IGF2BP1 overexpression was detected in ESCC tissues and associated with the depth of tumor invasion. In addition, IGF2BP1 mRNA expression in ESCC cells was negatively correlated with the level of its promoter methylation. Knockdown of IGF2BP1 inhibited ESCC cell invasion and migration as well as tumor metastasis. Mechanistically, we observed that IGF2BP1 bound and stabilized INHBA mRNA and then resulted in higher protein expression of INHBA, leading to the activation of Smad2/3 signaling, thus promoting malignant phenotypes. The mRNA level of INHBA was upregulated in ESCC tissues as well. Furthermore, IGF2BP1 interacted with G3BP stress granule assembly factor 1 (G3BP1). Knockdown of G3BP1 also down-regulated the INHBA-Smad2/3 signaling. BTYNB abolished this activated signaling and significantly attenuated the malignant phenotypes of ESCC cells. Conclusions: Elevated expression of IGF2BP1 is a frequent event in ESCC tissues and might be a candidate biomarker for the disease. IGF2BP1 overexpression promotes the invasion and migration of ESCC cells by activating the INHBA-Smad2/3 pathway, providing a potential therapeutic target for ESCC patients with high expression of IGF2BP1.

Expression Profile, Clinical Significance and Biological Functions of IGF2BP2 in Esophageal Squamous Cell Carcinoma.

Upregulation of IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression That Is Related to Cell Proliferation, Metastasis and Tumor-Infiltrating Immune Cells

Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells

Insulin‐like growth factor‐2 mRNA‐binding protein 3 promotes cell migration, invasion, and epithelial−mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E‐box‐binding homeobox 1 mRNA

Assessment Of Insulin-Like Growth Factor 1 Receptor As An Oncogene In Esophageal Squamous Cell Carcinoma And Its Potential Implication In Chemotherapy

Abstract 6847: IGF2BP3 promotes esophageal squamous cell carcinoma progressions via Wnt/CTNNB1 pathway

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

IGF2 induces CD133 expression in esophageal cancer cells to promote cancer stemness

Expression of EIF5A2 in Esophageal Squamous Cell Carcinoma and Its Correlation with the Prognosis

Overexpression of TFIIB-related Factor 2 is Significantly Correlated with Tumor Angiogenesis and Poor Survival in Patients with Esophageal Squamous Cell Cancer

Epigenetic Alterations of the Igf2 Promoter and the Effect of Mir‑483‑5p on Its Target Gene Expression in Esophageal Squamous Cell Carcinoma.

The m6A reader IGF2BP2 promotes ESCC progression by stabilizing HDGF mRNA

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma

Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

Clinical Significance of an M6a Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma.

IGF2BP2-induced Circrunx1 Facilitates the Growth and Metastasis of Esophageal Squamous Cell Carcinoma Through Mir-449B-5p/foxp3 Axis

The m6A reader IGF2BP2 promotes esophageal cell carcinoma progression by enhancing EIF4A1 translation

Prognostic modeling and Emerging therapeutic targets Unveiled through single-cell sequencing in esophageal squamous Cell carcinoma

Insights into the Role of the N6-methyladenosine Reader IGF2BP3 in the Progression of Oral Squamous Cell Carcinoma and Its Connection to Cell-Cycle Control

The Clinical Significance of Isocitrate Dehydrogenase 2 in Esophageal Squamous Cell Carcinoma.

IGF-1-mediated FOXC1 overexpression induces stem-like properties through upregulating CBX7 and IGF-1R in esophageal squamous cell carcinoma